Cryopyrin-associated Periodic Syndromes (CAPS)
4 clinical trials · Condition
◉ Watch Cryopyrin-associated Periodic Syndromes (CAPS)
| Record | Firm | Date |
|---|---|---|
| HL2351 CAPS Phase II Study (NCT02853084) | Handok Inc. | 2015-10-01 |
| Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients (NCT01213641) | Novartis Pharmaceuticals | 2009-11-01 |
Track Cryopyrin-associated Periodic Syndromes (CAPS) automatically
Every clearance here is in the API, with alerts when new ones post.